טוען...
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
PET using (18)F-FDG for treatment monitoring in patients with lymphoma is one of the most well-developed clinical applications. PET/CT is nowadays used during treatment to assess chemosensitivity, with response-adapted therapy given according to ‘interim’ PET in clinical practice to adults and child...
שמור ב:
| הוצא לאור ב: | Eur J Nucl Med Mol Imaging |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer Berlin Heidelberg
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5541086/ https://ncbi.nlm.nih.gov/pubmed/28411336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-017-3690-8 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|